Sort   by:  
 Page size 
ProteomicsPlasma-derived EV Phosphoproteomics through Chemical Affinity Purification
Invasive nature and pain caused to patients inhibit the routine use of tissue biopsy-based procedures for cancer diagnosis and surveillance. The analysis of extracellular vesicles (EVs) from biofluids have recently gained significant traction in the liquid biopsy field. EVs offer an essential “snaps...
ORGANISM(S): Homo sapiens (Human) 
2020-06-15 | PXD017994 | Pride
Exosomes Kidney cancer Phosphoproteomics Evtrap 
ProteomicsUrine EV Phosphoproteomics - Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles
Capture of urinary EVs with EVtrap and analysis of their phosphoproteome
ORGANISM(S): Homo sapiens (Human) 
2018-08-10 | PXD010480 | Pride
Exosomes Urine Evs Evtrap Phosphoproteomics 
ProteomicsPhosphoproteome Analysis of Cerebrospinal Fluid Extracellular Vesicles in Primary Central Nervous System Lymphoma
Primary central nervous system lymphoma(PCNSL) is a rare extra-nodal non-Hodgkin’s lymphoma and accounts for 3%-4% of central nervous system tumors. Recent studies have highlighted the importance of cerebrospinal fluid derived extracellular vesicles in PCNSL. Extracellular vesicles(EVs) are nanoscal...
ORGANISM(S): Homo Sapiens (human) 
PXD040744 | JPOST Repository
ProteomicsQuantitative proteomics and phosphoproteomics of urinary extracellular vesicles defines putative diagnosis biosignatures for Parkinson's Disease
Background: Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been recognized as genetic risk factors for Parkinson’s disease (PD). However, compared to cancer, fewer genetic mutations contribute to the cause of PD, propelling the search for protein biomarkers for early detection of th...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-07-21 | MSV000085800 | MassIVE
ProteomicsQuantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
Background: Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been recognized as genetic risk factors for Parkinson’s disease (PD). However, compared to cancer, fewer genetic mutations contribute to the cause of PD, propelling the search for protein biomarkers for early detection of th...
ORGANISM(S): Homo Sapiens 
2024-11-02 | PXD032175 | panorama
Sort   by:  
 Page size